- When a Biosimilar Might Increase Not Decrease Costs | Ravi Parikh, M.D., M.P.H., ASRS 2023 Managed Healthcare Executive
- ASRS 2023: Efficacy and safety of biosimilars ranibizumab-nuna and ranibizumab-eqrn in clinical use Ophthalmology Times
- View Full Coverage on Google News
Source link